Search

To compare the efficacy of platelet-rich plasma (PRP) injection vs dry needling (DN) for management of trigger points in the masseter muscle in myofascial pain syndrome (MPS) patients.This randomized controlled trial included 30 clinically confirmed cases of myofascial trigger points (MTrPs) in the masseter muscle who were randomly and equally (1:1) assigned to the test (PRP) and control (DN) groups. Both groups were evaluated for pain (visual analog scale [VAS]), range of functional movements, need for pain medication, patient satisfaction (Likert scale), and sleep (VAS) at baseline and 2-week, 1-month, and 3-month follow-ups. VAS pain and Likert score were also obtained at 6-month intervals.The use of PRP solution in MTrPs in MPS patients had a better effect on pain and patient satisfaction compared to DN.PRP appears to be a more effective treatment modality compared to DN in the management of MTrPs in MPS patients.

Mucormycosis is becoming more common in patients infected with or recovering from COVID-19 under the current situation. However, there is a scarcity of research on a specific group of COVID-19 individuals who are predisposed to mucormycosis. As a result, a retrospective observational study was undertaken to assess the possible connection of mucormycosis with COVID-19. The goal was also to investigate the link between diabetes mellitus, mucormycosis and COVID-19. The occurrence and severity of the disease among the case records were assessed using signs and symptoms, investigations conducted during COVID-19, and serological test results. Patients were classified as previously known diabetics, recently diagnosed diabetics, or non-diabetics based on their history of pre-existing DM and HBA1c levels at the time of reporting for mucormycosis. The findings show that mild COVID-19-infected patients and non-diabetic patients have a high incidence of COVID-19-associated mucormycosis (CAM). As a result, all clinicians participating in the care of COVID-infected patients must be aware of the significant risk of secondary mucormycosis in the post-recovery phase, even in those with mild or moderate symptoms.

We hereby report an unusual case which presented as a routinely encountered reactive lesion on the palate, whilst the radiological examination revealed a radiolucent cystic lesion underneath. After the investigations from radiography to histopathology, it was finally diagnosed as a peripheral ossifying fibroma coexisting with a nasopalatine duct cyst.

Introduction: Tuberculosis (TB) affects 8 million new people every year, with developing countries under its strong clout. Although tuberculosis can affect any part of the body involving both soft and hard tissues; such an occurrence in the maxillofacial bones in the form of tuberculous osteomyelitis is relatively rare. Due to the rarity of the lesion and lack of sufficient documentation, its incidence can be expected to be more than what has been reported so far. Observation: So, here is a case of a 21-year-old male who presented with pain and swelling on the mandible, diagnosed as tuberculous osteomyelitis after an initial diagnosis of dentoalveolar abscess. Conclusion: As dentists and as oral medicine practitioners, it is of utmost importance for us to be aware about uncommon diseases affecting the jaws such as tuberculous osteomyelitis, which tend to mimic dental infections in some cases to prevent misdiagnosis and provide holistic care to the patient.